In light of the novel data we provide herein, we conclude that abnormalities affecting cAMP effectors, CaMKII and Ca2+ proteins handling in DCM are complex and involve differential and time‐specific regulations. The gene discussed is CAMK2G; the disease is familial dilated cardiomyopathy.